Voriconazole (Pinapu) 50/200mg | Beijing Genetech Generic | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

مشاركة
Product description

Generic Information: Pinapu (China Generic)

Pinapu is a Chinese generic of voriconazole produced by Beijing Genetech Pharmaceutical Co., Ltd., an NMPA-approved manufacturer. The listing offers film-coated tablets in two strengths — 50 mg and 200 mg, each box of ten — mirroring the originator's dosage options at a fraction of the brand price, which matters for patients paying out of pocket for an extended antifungal course.

What Is Voriconazole (Pinapu) Used For?

The medicine serves the same serious indications as branded voriconazole: invasive aspergillosis, candida bloodstream infection in non-neutropenic patients, oesophageal candidiasis, and difficult Fusarium or Scedosporium infections. In Chinese clinical practice, generic voriconazole is widely used in haematology and transplant wards, and it is also prescribed on discharge to complete a course begun in hospital.

How Does Voriconazole Work?

Pinapu contains the identical active molecule that blocks fungal ergosterol synthesis. By inhibiting 14-alpha-demethylase inside the fungal cell, it prevents construction of the membrane lipid fungi depend on for survival, stopping growth and, against susceptible moulds, killing the organism outright. The mechanism is broad enough to cover both Candida yeasts and Aspergillus moulds.

Indications

Approved indications cover invasive aspergillosis, candidemia and deep-tissue candidiasis in non-neutropenic patients, oesophageal candidiasis, and refractory Fusarium or Scedosporium apiospermum disease. A clinician selects the drug after identifying the fungus and, because generic and brand voriconazole share the same metabolism, therapeutic drug monitoring guides safe dosing exactly as it does for the originator.

Dosage

Adults start with a 6 mg/kg loading dose every 12 hours for 24 hours, then maintain on 200 mg twice daily by mouth; the 50 mg tablet allows finer weight-based or paediatric adjustments. Patients under 40 kg take 100 to 150 mg twice daily. The twice-daily oral route makes home continuation practical, and dosing is reduced by half in mild-to-moderate hepatic impairment.

Side Effects

The most distinctive effect is transient visual disturbance — blurring, photophobia or colour changes — usually reversible. Rash, nausea, headache and elevated liver enzymes are also common, while hepatic injury, QT prolongation and photosensitivity reactions are the serious events that demand monitoring. Patients should limit sun exposure and report any new visual symptom to the prescribing team.

Storage

Pinapu tablets are stable at room temperature in sealed packaging, requiring no refrigeration. Ambient-condition shipping preserves quality, and GLT dispatches from a Hong Kong-licensed facility with batch documentation and certificate of analysis included in every shipment.

Why Choose Pinapu Through GLT?

For self-funded patients the difference between brand and generic voriconazole can run into hundreds of dollars over a multi-week course. Pinapu delivers the same molecule with NMPA-approved manufacturing quality, and GLT's Hong Kong base makes this Chinese generic accessible to overseas buyers with transparent sourcing and batch traceability.

How to Order

To order Pinapu (voriconazole) from GLT, message us on WhatsApp at +86 15234153837 or email [email protected]. We confirm current stock, pack availability and delivery cost to your country, and ship from a Hong Kong-licensed facility.

FAQ

Is Pinapu the same as Vfend? Pinapu is a Chinese generic containing the same voriconazole molecule as the Pfizer originator Vfend, in matching 50 mg and 200 mg strengths.

Why two strengths? 200 mg is the standard adult dose, while 50 mg supports weight-based and paediatric adjustments.

Does a generic work the same? Yes — Chinese generics are approved after demonstrating bioequivalence to the originator.

Related Oncology Products

بارينيب (باريسيتينيب) 2ملغ | مثبط JAK1/JAK2 جنيس | دراغ إنترناشيونال المحدودة | GLT

باريسيتينيب جنيس (مثبط JAK1/JAK2) من دراغ إنترناشيونال المحدودة (بنغلاديش) — بديل ميسور التكلفة عن أولوميانت...

أورفورغليبرون (لوسيورفور) أقراص 0.8–17.2 ملغ | دواء جينيريك لاوسي فموي GLP-1 | GLT

جينيريك أورفورغليبرون من Lucius Pharmaceuticals (لاوس)، نظام معايرة من 6 جرعات لإدارة الوزن

زيباوند (تيرزيباتيد) 2.5–15ملغ/0.5مل قلم أحادي الجرعة | إيلي ليلي (الولايات المتحدة) | GLT

زيباوند — قلم أحادي الجرعة من تيرزيباتيد إيلي ليلي، بستة جرعات أمريكية (2.5–15ملغ/0.5مل) لإدارة الوزن...

أولوميانت (باريسيتينيب) أقراص 2ملغ/4ملغ | مثبط JAK1/JAK2 | إيلي ليلي (الولايات المتحدة) | GLT

مثبط انتقائي لـ JAK1/JAK2 من إيلي ليلي لعلاج التهاب المفاصل الروماتويدي والتهاب الجلد التأتبي والثعلبة...

Rizonib (كريزوتينيب) كبسولات 250 ملغ | بديل Xalkori الجنيس من DIL بنغلاديش لسرطان الرئة ALK+ | GLT

Rizonib 250 من Drug International Ltd (DIL)، تونغي غازيبور — بديل كريزوتينيب جنيس ميسور التكلفة...

Avabopa (أفاترومبوباغ) 20 مجم × 30 قرص | Tongmeng TLPH لاوس | GLT

Avabopa — أفاترومبوباغ 20 مجم من Tongmeng (Lao) Pharmaceutical and Food Co., Ltd. (TLPH)، تسجيل...

إلترومبوباغ (Promacta) أقراص 25/50 ملغ | ناهض TPO-R أصلي أمريكي | GLT

Promacta الأصلي من Novartis (إلترومبوباغ) 25 ملغ و50 ملغ، 30 قرصًا

أورفورغليبرون (OriYo) أقراص 0.8–17.2 ملغ | دواء جينيريك بنغلاديشي فموي GLP-1 | GLT

جينيريك أورفورغليبرون من National Drug Co. (بنغلاديش)، نظام معايرة من 6 جرعات لإدارة الوزن